Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Vista Pharmaceuticals Ltd (NSE: VISTAPH), ISIN INE427C01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VISTAPH last traded at ₹6.77 (+0.45%), with a 52-week range of ₹5.32 to ₹10.10 (as of 6 Nov 2026).
Shareholding as of Jun 2026: promoters 21.19%, FIIs 0.00%, DIIs 0.02%, mutual funds 0.02%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.